AMBER LOVITT: Open Payments
NPI 1518506104 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 45 payments from 16 companies in 2025. Trend: 2023 $135 · 2024 $170 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $194 |
| Novo Nordisk Inc | 10 | $180 |
| Eisai Inc. | 3 | $76 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| PFIZER INC. | 2 | $54 |
| Dexcom, Inc. | 2 | $48 |
| Antares Pharma, Inc. | 1 | $35 |
| Acella Pharmaceuticals, LLC | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
Products named: QULIPTA, Leqembi, SYNTHROID, Wegovy, SHINGRIX, Dexcom G6 Transmitter, Rybelsus, XYOSTED.
Industry payments across TX — which companies pay providers there.
